Literature DB >> 18580318

Primary ovarian rhabdomyosarcoma with heterologous elements: a case report.

Daniela S Allende1, Bin Yang.   

Abstract

Primary ovarian rhabdomyosarcoma with heterologous elements is a rare ovarian neoplasm. Most cases reported in the English literature were associated either with teratomas or with mixed mullerian tumors. Pure primary rhabdomyosarcoma is extremely uncommon. We present hereby a case of primary pure embryonal rhabdomyosarcoma in a 25-year-old woman, showing heterologous elements, but associated neither with teratoma nor with mixed mullerian tumors.

Entities:  

Mesh:

Year:  2008        PMID: 18580318     DOI: 10.1097/PGP.0b013e3181659178

Source DB:  PubMed          Journal:  Int J Gynecol Pathol        ISSN: 0277-1691            Impact factor:   2.762


  5 in total

1.  Primary ovarian rhabdomosarcoma.

Authors:  Asim Qureshi; Usman Hassan; Rakshanda Rehman
Journal:  BMJ Case Rep       Date:  2011-04-01

2.  Embryonal rhabdomyosarcoma of the uterine cervix: a report of 14 cases and a discussion of its unusual clinicopathological associations.

Authors:  Louis P Dehner; Jason A Jarzembowski; D Ashley Hill
Journal:  Mod Pathol       Date:  2011-12-09       Impact factor: 7.842

3.  Embryonal rhabdomyosarcoma of the uterine corpus: a clinicopathological and molecular analysis of 21 cases highlighting a frequent association with DICER1 mutations.

Authors:  Jennifer A Bennett; Zehra Ordulu; Robert H Young; Andre Pinto; Koen Van de Vijver; Eike Burandt; Pankhuri Wanjari; Rajeev Shah; Leanne de Kock; William D Foulkes; W Glenn McCluggage; Lauren L Ritterhouse; Esther Oliva
Journal:  Mod Pathol       Date:  2021-05-20       Impact factor: 7.842

4.  Adipocyte-Like Differentiation in a Posttreatment Embryonal Rhabdomyosarcoma.

Authors:  Dana Balitzer; Timothy H McCalmont; Andrew E Horvai
Journal:  Case Rep Pathol       Date:  2015-12-10

5.  Endometriosis Malignant Transformation Review: Rhabdomyosarcoma Arising From an Endometrioma.

Authors:  Camran Nezhat; Mailinh Vu; Nataliya Vang; Kristen Ganjoo; Amer Karam; Ann Folkins; Azadeh Nezhat; Farr Nezhat
Journal:  JSLS       Date:  2019 Oct-Dec       Impact factor: 2.172

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.